A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer
- Author
- Veerle Surmont (UGent) , JGJV Aerts, RJ van Klaveren, K Tournoy, KY Tan, RM Vernhout, PIM Schmitz, C Legrand, HC Hoogsteden and JP van Meerbeeck
- Organization
- Keywords
- Toxicity, Chemotherapy, Non-small cell lung cancer, CLINICAL-TRIALS, Gemcitabine, Carboplatin, CISPLATIN, METAANALYSIS, GEMCITABINE/CARBOPLATIN, CHEMOTHERAPY, TOXICITY
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 105.82 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-1186503
- MLA
- Surmont, Veerle, et al. “A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer.” ONCOLOGY, vol. 78, no. 3–4, 2010, pp. 267–70, doi:10.1159/000315733.
- APA
- Surmont, V., Aerts, J., van Klaveren, R., Tournoy, K., Tan, K., Vernhout, R., … van Meerbeeck, J. (2010). A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. ONCOLOGY, 78(3–4), 267–270. https://doi.org/10.1159/000315733
- Chicago author-date
- Surmont, Veerle, JGJV Aerts, RJ van Klaveren, K Tournoy, KY Tan, RM Vernhout, PIM Schmitz, C Legrand, HC Hoogsteden, and JP van Meerbeeck. 2010. “A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer.” ONCOLOGY 78 (3–4): 267–70. https://doi.org/10.1159/000315733.
- Chicago author-date (all authors)
- Surmont, Veerle, JGJV Aerts, RJ van Klaveren, K Tournoy, KY Tan, RM Vernhout, PIM Schmitz, C Legrand, HC Hoogsteden, and JP van Meerbeeck. 2010. “A Randomized Phase II Study Comparing Two Schedules of the 21-Day Regimen of Gemcitabine and Carboplatin in Advanced Non-Small Cell Lung Cancer.” ONCOLOGY 78 (3–4): 267–270. doi:10.1159/000315733.
- Vancouver
- 1.Surmont V, Aerts J, van Klaveren R, Tournoy K, Tan K, Vernhout R, et al. A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer. ONCOLOGY. 2010;78(3–4):267–70.
- IEEE
- [1]V. Surmont et al., “A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer,” ONCOLOGY, vol. 78, no. 3–4, pp. 267–270, 2010.
@article{1186503, author = {{Surmont, Veerle and Aerts, JGJV and van Klaveren, RJ and Tournoy, K and Tan, KY and Vernhout, RM and Schmitz, PIM and Legrand, C and Hoogsteden, HC and van Meerbeeck, JP}}, issn = {{0030-2414}}, journal = {{ONCOLOGY}}, keywords = {{Toxicity,Chemotherapy,Non-small cell lung cancer,CLINICAL-TRIALS,Gemcitabine,Carboplatin,CISPLATIN,METAANALYSIS,GEMCITABINE/CARBOPLATIN,CHEMOTHERAPY,TOXICITY}}, language = {{eng}}, number = {{3-4}}, pages = {{267--270}}, title = {{A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer}}, url = {{http://doi.org/10.1159/000315733}}, volume = {{78}}, year = {{2010}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: